Client’s Testimonial:
“I have already referred WeGreened to my friends. You are very professional and your network communication platform is also great. I appreciate your good service.”
On March 16th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for an Associate Professor in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Associate Professor
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: March 16th, 2016
Processing Time: 6 Days (Premium Processing Requested)
Case Summary:
An associate professor engaged the services of North America Immigration Law Group (WeGreened.com) to help her attain green cards for herself and her family. After evaluating her qualifications, we approved her request to file her I-140 petition under the EB-1A (Alien of Extraordinary Ability) visa category. Because our client elected to file her petition using the Premium Processing option, we received an approval notice merely six days after the petition was filed.
Seeing that EB-1A petitions are held to a very high standard of law, we had to ensure that our presentation was flawless and clearly demonstrated the value of our client’s work to the United States. Amongst other things, we listed her citation count (nearly 300 citations), publication record (35 published papers), and peer review experience (40 reviews). We also detailed the fact that our client served as an editorial board member for two prominent scientific journals at the time of filing. Besides listing our client’s professional triumphs, we also noted her scholarly achievements: her Ph.D. obtained from a university in her birth country of China and a copy of her degree.
Additional Evidence:
We used recommendation letters endorsed by other expert pharmacologists as additional evidence to strengthen our EB1A petition packet. These letters supported our claim that our client’s work on epigenetic pharmacology and pain pharmacology—with a particular emphasis on tumor epigenetic therapy and chronic pain targets—are of great value to the United States. According to one of our client’s recommenders, “The work conducted by [Client] is an amazing achievement in cancer epigenetic studies and puts the field ever-closer to eradicating myriad cancers. Our inquiries could not be unfolding at better time, as cancer is still responsible for 8.2 million deaths worldwide and new cases of cancer are expected to surge up to 22 million within the next two decades.” Another prominent member of the field stated, “I am unaware of anyone more qualified than [Client] undertaking research that is so central to understanding and eradicating chronic pain for the nerve—injured. Chronic pain remains a primary cause of long—term disability, keeping individuals from working or otherwise enjoying their lives to the fullest…”
Final Step towards a Green Card:
Not long after we received a notice from Nebraska Service Center informing us that our client’s petition had been approved, we set to work putting together I-485 applications for her and her two dependents. We recently filed the applications and look forward to a favorable response from the USCIS. Till then, we would like to thank our client for choosing our law firm to help her obtain permanent residency, and we wish her well as she continues to advance her field of pharmacology.